Evidence map›Paper›PMID 25327839›Full record

ArticleGlia2015

Nitric oxide targets oligodendrocytes and promotes their morphological differentiation.

Giti Garthwaite, Kathryn Hampden-Smith, Gary W Wilson, David A Goodwin, John Garthwaite

Open access · hybridAbstract read
In one paragraph

Article in Glia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Mechanisms Involved in the Remyelinating Effect of Sildenafil.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. A new small molecule inhibitor of soluble guanylate cyclase.Bioorganic & medicinal chemistry · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Giti GarthwaiteWolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, United Kingdom.
Kathryn Hampden-Smith
Gary W Wilson
David A Goodwin
John Garthwaite
University College London · GB

Funding

Wellcome Trust 081512
6 · The paper itself

Abstract

In the central nervous system, nitric oxide (NO) transmits signals from one neurone to another, or from neurones to astrocytes or blood vessels, but the possibility of oligodendrocytes being physiological NO targets has been largely ignored. By exploiting immunocytochemistry for cGMP, the second messenger generated on activation of NO receptors, oligodendrocytes were found to respond to both exogenous and endogenous NO in cerebellar slices from rats aged 8 days to adulthood. Atrial natriuretic peptide, which acts on membrane-associated guanylyl cyclase-coupled receptors, also raised oligodendrocyte cGMP in cerebellar slices. The main endogenous source of NO accessing oligodendrocytes appeared to be the neuronal NO synthase isoform, which was active even under basal conditions and in a manner that was independent of glutamate receptors. Oligodendrocytes in brainstem slices were also shown to be potential NO targets. In contrast, in the optic nerve, oligodendrocyte cGMP was raised by natriuretic peptides but not NO. When cultures of cerebral cortex were continuously exposed to low NO concentrations (estimated as 40-90 pM), oligodendrocytes responded with a striking increase in arborization. This stimulation of oligodendrocyte growth could be replicated by low concentrations of 8-bromo-cGMP (maximum effect at 1 µM). It is concluded that oligodendrocytes are probably widespread targets for physiological NO (or natriuretic peptide) signals, with the resulting rise in cGMP serving to enhance their growth and maturation. NO might help coordinate the myelination of axons to the ongoing level of neuronal activity during development and could potentially contribute to adaptive changes in myelination in the adult.

Indexed as

AnimalsBrainCell DifferentiationCells, CulturedCyclic GMPMaleMice, 129 StrainMice, Inbred C57BLMice, KnockoutNatriuretic PeptidesNitric OxideNitric Oxide Synthase Type INitric Oxide Synthase Type IIIOligodendrogliaProtein Kinase InhibitorsRats, Sprague-Dawley8-bromocyclic GMPCyclic GMPNatriuretic PeptidesNitric OxideNitric Oxide Synthase Type INitric Oxide Synthase Type IIINos1 protein, ratNos3 protein, mouseProtein Kinase InhibitorsbrainstemcerebellumcGMPmyelinationnatriuretic peptideoptic nerve

Identifiers

PMID25327839
PMCPMC4309495
OpenAlexW1585472696

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.